Regulators allege the $142.5 million deal to buy the remaining stake in San Ramon Regional Medical Center would further reduce competition and drive up prices.
Regulators allege the $142.5 million deal to buy the remaining stake in San Ramon Regional Medical Center would further reduce competition and drive up prices.